000811686 001__ 811686
000811686 005__ 20220930130102.0
000811686 0247_ $$2doi$$a10.3389/fneur.2016.00120
000811686 0247_ $$2Handle$$a2128/11974
000811686 0247_ $$2WOS$$aWOS:000381072100001
000811686 0247_ $$2altmetric$$aaltmetric:10082026
000811686 0247_ $$2pmid$$apmid:27516754
000811686 037__ $$aFZJ-2016-04070
000811686 082__ $$a610
000811686 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author$$ufzj
000811686 245__ $$aAmino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
000811686 260__ $$aLausanne$$bFrontiers Research Foundation$$c2016
000811686 3367_ $$2DRIVER$$aarticle
000811686 3367_ $$2DataCite$$aOutput Types/Journal article
000811686 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1469782698_12550
000811686 3367_ $$2BibTeX$$aARTICLE
000811686 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000811686 3367_ $$00$$2EndNote$$aJournal Article
000811686 520__ $$aRoutine diagnostics and treatment monitoring in patients with primary and secondary brain tumors is usually based on contrast-enhanced standard MRI. However, the capacity of standard MRI to differentiate neoplastic tissue from non-specific posttreatment effects may be limited particularly after therapeutic interventions such as radio- and/or chemotherapy or newer treatment options, e.g., immune therapy. Metabolic imaging using PET may provide relevant additional information on tumor metabolism, which allows a more accurate diagnosis especially in clinically equivocal situations, particularly when radiolabeled amino acids are used. Amino acid PET allows a sensitive monitoring of a response to various treatment options, the early detection of tumor recurrence, and an improved differentiation of tumor recurrence from posttherapeutic effects. In the past, this method had only limited availability due to the use of PET tracers with a short half-life, e.g., C-11. In recent years, however, novel amino acid PET tracers labeled with positron emitters with a longer half-life (F-18) have been developed and clinically validated, which allow a more efficient and cost-effective application. These developments and the well-documented diagnostic performance of PET using radiolabeled amino acids suggest that its application continues to spread and that this technique may be available as a routine diagnostic tool for several indications in the field of neuro-oncology.
000811686 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000811686 588__ $$aDataset connected to CrossRef
000811686 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b1$$ufzj
000811686 773__ $$0PERI:(DE-600)2564214-5$$a10.3389/fneur.2016.00120$$gVol. 7$$p120$$tFrontiers in neurology$$v7$$x1664-2295$$y2016
000811686 8564_ $$uhttps://juser.fz-juelich.de/record/811686/files/fneur-07-00120.pdf$$yOpenAccess
000811686 8564_ $$uhttps://juser.fz-juelich.de/record/811686/files/fneur-07-00120.gif?subformat=icon$$xicon$$yOpenAccess
000811686 8564_ $$uhttps://juser.fz-juelich.de/record/811686/files/fneur-07-00120.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000811686 8564_ $$uhttps://juser.fz-juelich.de/record/811686/files/fneur-07-00120.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000811686 8564_ $$uhttps://juser.fz-juelich.de/record/811686/files/fneur-07-00120.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000811686 8564_ $$uhttps://juser.fz-juelich.de/record/811686/files/fneur-07-00120.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000811686 8767_ $$92016-06-03$$d2016-06-03$$eAPC$$jDeposit$$lDeposit: Frontiers$$zUSD 805,-
000811686 909CO $$ooai:juser.fz-juelich.de:811686$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000811686 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000811686 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000811686 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000811686 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000811686 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000811686 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aClarivate Analytics Master Journal List
000811686 9141_ $$y2016
000811686 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
000811686 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b1$$kFZJ
000811686 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000811686 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000811686 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000811686 9801_ $$aFullTexts
000811686 980__ $$ajournal
000811686 980__ $$aVDB
000811686 980__ $$aUNRESTRICTED
000811686 980__ $$aI:(DE-Juel1)INM-3-20090406
000811686 980__ $$aI:(DE-Juel1)INM-4-20090406
000811686 980__ $$aAPC
000811686 981__ $$aI:(DE-Juel1)INM-4-20090406